(The Center Square) – Medicare Part D sponsors made $587.7 million in ineligible payments to pharmacies for five drugs carrying obsolete prescription-only labeling more than a year after the corresponding brand-name drugs switched to over-the-counter status, a federal watchdog found.
From
To
Ozempic Insulin box and injection pen or insulin cartridge pen for diabetes patients from Novo Nordisk
Happy senior couple buying prescription medicine in pharmacy.
(The Center Square) – The Centers for Medicare and Medicaid Services proposed changes to reduce prescription drug costs for Medicare Advantage…
Each year, Medicare comes with a new set of prices, new plan ratings and sometimes new regulations. What you’ll pay may be different from last…